Lindsay Bealor Greenleaf Weighs in on the Administration’s Plan to Cut Out the Middlemen in Medicare Part D
Lindsay Bealor Greenleaf, director at ADVI Health, a consulting firm specializing in reimbursement, said it was a “great” step to limit the take of pharmacy benefit managers. “Reforming the role played by PBM middlemen, and ensuring that patients actually benefit from the discounts PBMs receive, is critical to reducing patient out-of-pocket drug costs,” she said.
[el-text]
Written by Kimberly Marselas
Wednesday, February 14, 2018
Lindsay Bealor Greenleaf, director at ADVI Health, a consulting firm specializing in reimbursement, said it was a “great” step to limit the take of pharmacy benefit managers. “Reforming the role played by PBM middlemen, and ensuring that patients actually benefit from the discounts PBMs receive, is critical to reducing patient out-of-pocket drug costs,” she said.
[/el-text]
View full article here
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.